Top Markets
Coin of the day
Medigen Biotechnology Corp. Medigen Biotechnology Corp.

Medigen Biotechnology Corp.

3176
Rang în acțiuni #19061
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated... Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
Preț acțiune
$1.27
Capitalizare de piață
$176.31M
Schimbare (1 zi)
5.57%
Schimbare (1 an)
29.36%
Țară
TW
Tranzacționează Medigen Biotechnology Corp. (3176)

Categorie

Istoricul spliturilor pentru Medigen Biotechnology Corp. (3176)
Acțiunea Medigen Biotechnology Corp. (simbol: 3176) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 26, 2026.
O acțiune 3176 cumpărată înainte de Aug 26, 2026 este echivalentă astăzi cu 0 acțiuni 3176.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH